A potential explanation for these results is the number of samples included in this study (n = 12 nonfibrotic control and n = 12 IPF specimens, with 6 harboring the MUC5B promoter variant per group). This evidence concerns the gene MUC5B and idiopathic pulmonary fibrosis.